|
Market Closed -
OTC Markets
03:25:34 2026-10-01 pm EDT
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | 0.00% |
|
0.00% | -87.50% |
| Market Cap | 300K 266K 249K 227K 427K 28.86M 433K 3.01M 1.17M 14.7M 1.13M 1.1M 47.2M | P/E 2024 |
-1.46x | P/E 2025 | -0.03x |
|---|---|---|---|---|---|
| Enterprise Value | 5.07M 4.5M 4.21M 3.84M 7.22M 488M 7.32M 50.91M 19.71M 248M 19.02M 18.61M 798M | EV / Sales 2024 |
2.08x | EV / Sales 2025 | 1.78x |
| Free-Float |
91.71% | Yield 2024 * |
-
| Yield 2025 | - |
| 6 months | -50.00% | ||
| Current year | -87.50% |
| 1 week | 0 | 0 | |
| 1 month | 0 | 0 | |
| Current year | 0 | 0 | |
| 1 year | 0 | 0.01 | |
| 3 years | 0 | 0.1 | |
| 5 years | 0 | 11.5 | |
| 10 years | 0 | 11.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charles Arnold
CEO | Chief Executive Officer | 75 | 2021-08-18 |
| Director of Finance/CFO | 41 | 2025-04-14 | |
John Meyer
PSD | President | 72 | 2021-08-18 |
| Director | Title | Age | Since |
|---|---|---|---|
Charles Arnold
CHM | Chairman | 75 | 2021-08-18 |
John Meyer
BRD | Director/Board Member | 72 | 2021-08-18 |
Benjamin Kaplan
BRD | Director/Board Member | 54 | 2021-09-16 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/23/25 | Sell | Director | 1,000,000 | 0.7421% | ||
| 7/26/24 | Other | Chief Executive Officer | 25,000 | 0.0239% | ||
| 4/19/24 | Mindshare Holdings, Inc.
| Sell | Company | 25,000 | 0.0239% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | -99.17% | -99.74% | 300K | ||
| -0.62% | -2.71% | +39.30% | +114.07% | 1,031B | ||
| -2.30% | -4.44% | +39.03% | +66.07% | 638B | ||
| -0.63% | -1.96% | +6.36% | +74.38% | 462B | ||
| -1.03% | -2.82% | +59.56% | +39.69% | 359B | ||
| -0.03% | -3.96% | +23.63% | +39.35% | 335B | ||
| -1.58% | -0.76% | +13.50% | +25.77% | 273B | ||
| -2.02% | -2.97% | -3.25% | +8.38% | 253B | ||
| -3.38% | +0.30% | +36.44% | +51.54% | 228B | ||
| -1.04% | -1.46% | +32.70% | +96.82% | 185B | ||
| Average | -1.26% | -1.42% | +14.81% | +41.63% | 376.39B | |
| Weighted average by Cap. | -1.25% | -1.89% | +30.52% | +69.18% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 5.05M 4.49M 4.2M 3.83M 7.2M 487M 7.3M 50.78M 19.66M 248M 18.97M 18.56M 796M | 2.88M 2.55M 2.39M 2.18M 4.1M 277M 4.16M 28.9M 11.19M 141M 10.8M 10.57M 453M |
| Net income | -3.77M -3.35M -3.13M -2.85M -5.37M -363M -5.45M -37.88M -14.66M -185M -14.15M -13.85M -594M | -4.05M -3.59M -3.36M -3.06M -5.77M -390M -5.85M -40.66M -15.74M -198M -15.19M -14.86M -637M |
| Net Debt | 4.23M 3.76M 3.52M 3.2M 6.03M 408M 6.12M 42.54M 16.47M 208M 15.9M 15.55M 667M | 4.77M 4.23M 3.96M 3.61M 6.79M 459M 6.89M 47.9M 18.54M 234M 17.9M 17.51M 751M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-01 | $0.000100 | 0.00% | 173,800 |
| 26-09-30 | $0.000100 | 0.00% | 999,859 |
| 26-09-29 | $0.000100 | +9,900.00% | 100,000 |
| 26-09-28 | $0.000001 | 0.00% | 1,125,183 |
| 26-09-25 | $0.000001 | -99.00% | 2,047 |
- Stock Market
- Stocks
- STEK Stock
Select your edition
All financial news and data tailored to specific country editions
















